AbbVie stock slips today as Fed minutes loom in thin year-end trade
AbbVie shares fell 0.8% to $228.89 in midday New York trading Tuesday, underperforming the S&P 500 and healthcare sector peers. The drop came as investors awaited Federal Reserve minutes and traded cautiously in thin, year-end markets. Merck, Johnson & Johnson, and Amgen also slipped. AbbVie’s next earnings report is scheduled for Feb. 4, 2026.